London Stock Exchange ETF segment · UCITS ETF
Invest in BIOT ETF from India
Indian and foreign residents can buy L&G Pharma Breakthrough UCITS ETF (BIOT) units directly through Paasa.
By Paasa · Updated
BIOT at a glance
- Price
- $14.58-$0.30 (2.00%)
- Expense ratio
- 0.49%
- Day range
- $14.58 – $14.81
- Assets
- $24.5M
- Domicile
- Ireland
- Holdings
- —
- Launched
- 2018
- Dividends
- —
- 1 month
- -6.75%
- 6 months
- +5.68%
- YTD
- +6.69%
- 1 year
- +13.05%
- 5 years
- +13.54%
Price change, excluding dividends.
Top 10 holdings
- 1XERIS BIOPHARMA HLDGS IN USD 0.00012.9%
- 2UNITED THERAPEUTICS CORP D USD 0.012.9%
- 3LIGAND PHARMACEUTICALS IN USD 0.0012.8%
- 4BASILEA PHARMACEUTICA AG AL CHF 1.02.7%
- 5GENMAB AS DKK12.7%
- 6EISAI CO LTD NPV2.6%
- 7BIOGEN INC2.6%
- 8BEONE MEDICINES LTD USD 0.0001 ADR2.6%
- 9ASTRAZENECA PLC USD 0.252.6%
- 10AGIOS PHARMACEUTICALS INC USD 0.0012.6%
These 10 are 27.0% of the fund.
Where the money is invested
Sectors
- Healthcare97.9%
- Basic Materials2.1%
Countries
- United States60.4%
- Japan9.7%
- Switzerland5.2%
- Denmark2.7%
- United Kingdom2.6%
- Italy2.5%
How to invest in BIOT from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit.
Step 3
Search BIOT and buy
Find the fund by its ticker, BIOT, on the London Stock Exchange ETF segment, and place your order.
Why invest in BIOT from India
What BIOT holds
The L&G Pharma Breakthrough UCITS ETF is designed to mirror the financial performance generated by the Solactive Pharma Breakthrough Value Index.
Outside US estate tax
BIOT is domiciled in Ireland, not the US, so it is not a US-situs asset and US estate tax does not apply to it.
Hold a dollar asset
BIOT is priced in US dollars, so a weaker rupee adds to what it's worth in rupees. The rupee depreciated over 85% against the dollar between 2010 and 2025.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Why BIOT's UCITS structure matters for Indian investors
BIOT is domiciled in Ireland, not the US, so it is not a US-situs asset and US estate tax does not apply to it.
On the US shares the fund holds, the 15% US dividend withholding is paid inside the fund, and you cannot claim it as a Foreign Tax Credit in India.
Capital gains are taxed in India the same way as on a US-listed ETF.
Frequently asked questions
Can I buy BIOT from India?
Yes. Indian residents can buy L&G Pharma Breakthrough UCITS ETF (BIOT) through Paasa. It is listed on the London Stock Exchange ETF segment and trades in US dollars. Your money leaves India under the RBI's Liberalised Remittance Scheme, and the units are held in your own name at Interactive Brokers.
What does BIOT invest in?
Its largest holdings are XERIS BIOPHARMA HLDGS IN USD 0.0001 (2.9%), UNITED THERAPEUTICS CORP D USD 0.01 (2.9%) and LIGAND PHARMACEUTICALS IN USD 0.001 (2.8%). Healthcare is its largest sector at 97.9%. The fund is domiciled in Ireland.
What is the expense ratio of BIOT?
L&G Pharma Breakthrough UCITS ETF has an expense ratio of 0.49% a year, taken from the fund's assets rather than billed to you. The fund manages about $24.5M.
Is BIOT a UCITS ETF, and why does that matter for Indian investors?
Yes. L&G Pharma Breakthrough UCITS ETF is a UCITS fund domiciled in Ireland. Because it is domiciled outside the US, it is not a US-situs asset, so US estate tax does not apply to it. On the US shares the fund holds, the 15% US dividend withholding is paid inside the fund, and you cannot claim it as a Foreign Tax Credit in India.
What tax do I pay in India when I sell BIOT?
In India, gains on foreign ETF units held for more than 24 months are long-term and taxed at 12.5% without indexation, and gains on units held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the USD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.